Takara Bio is committed to the fight against antimicrobial resistance
We are in the midst of a rise in levels of antimicrobial resistance (AMR). The amplification of AMR results in an increasing number of infections that are more challenging—and sometimes impossible—to treat effectively. AMR is now one of the greatest threats to both human health and the systems in place to safeguard it.
To help address the need for an improved understanding of this threat, Takara Bio and its partners are committed to delivering solutions for detecting AMR in the environment.
An article published in USA Today describes how the SmartChip Real-Time PCR System offers flexibility, speed, and cost benefits to help users such as Resistomap deliver solutions to efficiently monitor AMR in environmental samples. This, in turn, helps control the spread of AMR and manage its threat.
Read the full article: https://www.futureofpersonalhealth.com/antibiotic-resistance/new-tools-in-the-fight-against-antimicrobial-resistance/
Detection and quantification of antibiotic resistance genes and SARS-CoV-2 in wastewater
See how Resistomap developed methods for detection and quantification of antibiotic resistance genes (ARGs) and SARS-CoV-2 in environmental samples using the SmartChip Real-Time qPCR System.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2023 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.
